0.734
price up icon3.38%   0.024
pre-market  Pre-mercato:  .73   -0.004   -0.54%
loading
Precedente Chiudi:
$0.71
Aprire:
$0.7261
Volume 24 ore:
46,996
Relative Volume:
0.30
Capitalizzazione di mercato:
$28.64M
Reddito:
$135.87M
Utile/perdita netta:
$72.20M
Rapporto P/E:
0.5169
EPS:
1.42
Flusso di cassa netto:
$45.09M
1 W Prestazione:
-3.42%
1M Prestazione:
+0.55%
6M Prestazione:
-32.04%
1 anno Prestazione:
-66.94%
Intervallo 1D:
Value
$0.726
$0.738
Intervallo di 1 settimana:
Value
$0.7008
$0.7726
Portata 52W:
Value
$0.66
$2.26

Scynexis Inc Stock (SCYX) Company Profile

Name
Nome
Scynexis Inc
Name
Telefono
201-884-5485
Name
Indirizzo
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Name
Dipendente
29
Name
Cinguettio
@scynexis
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
SCYX's Discussions on Twitter

Confronta SCYX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
SCYX
Scynexis Inc
0.734 27.70M 135.87M 72.20M 45.09M 1.42
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.45 67.31B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.74 45.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.75 43.35B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.58 18.68B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.61 13.44B 2.99B 1.21B 1.13B 25.06

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-01-22 Iniziato Guggenheim Buy
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2018-07-11 Aggiornamento Needham Hold → Buy
2018-06-27 Iniziato Maxim Group Buy
2017-10-24 Iniziato Guggenheim Buy
2017-07-10 Iniziato ROTH Capital Buy
2017-05-09 Downgrade Needham Buy → Hold
2017-03-03 Reiterato RBC Capital Mkts Outperform
2016-10-20 Iniziato H.C. Wainwright Buy
2016-10-07 Aggiornamento WBB Securities Buy → Strong Buy
2016-10-03 Ripresa Brean Capital Buy
2016-08-17 Iniziato Guggenheim Buy
2016-08-09 Reiterato Needham Buy
2016-08-09 Aggiornamento WBB Securities Speculative Buy → Buy
2016-03-28 Iniziato Brean Capital Buy
2015-12-29 Iniziato WBB Securities Speculative Buy
2015-11-16 Reiterato RBC Capital Mkts Outperform
2015-06-10 Iniziato Needham Buy
2014-05-29 Iniziato Canaccord Genuity Buy
2014-05-29 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Scynexis Inc Borsa (SCYX) Ultime notizie

pulisher
Jul 23, 2025

Is SCYNEXIS Inc. a good long term investmentFree Investment Risk Control - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SCYNEXIS Inc. stock priceUnmatched market performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about SCYNEXIS Inc. stockUnstoppable profit momentum - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

SCYNEXIS Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Is ATH.PRA a good long term investmentSkyrocketing returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 16, 2025

What makes SCYNEXIS Inc. stock price move sharplyTop Analyst Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why SCYNEXIS Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SCYNEXIS Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Scynexis Inc (SCYX) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Jul 15, 2025
pulisher
Jul 02, 2025

SCYNEXIS Holds Annual Meeting, Re-elects Directors - The Globe and Mail

Jul 02, 2025
pulisher
Jun 26, 2025

SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price - TipRanks

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys New Holdings in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Biosergen taps antifungal expert as board member - Biostock

Jun 05, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $186,000 Stake in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 03, 2025
pulisher
May 29, 2025

Scynexis resumes dosing in Phase III MARIO study after lengthy delay - MSN

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold - Insider Monkey

May 29, 2025
pulisher
May 28, 2025

Scynexis resumes patient dosing in Phase 3 MARIO study - TipRanks

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing In Phase 3 MARIO Study - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX St - GuruFocus

May 28, 2025
pulisher
May 28, 2025

GSK Involved in SCYNEXIS's Phase 3 Study Milestone Dispute | GSK Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study - The Manila Times

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Restarts Critical Phase 3 Trial for Life-Threatening Infection, Faces $30M GSK Payment Battle - Stock Titan

May 28, 2025
pulisher
May 19, 2025

SCYNEXIS Faces Challenges Amidst Antifungal Developments - TipRanks

May 19, 2025

Scynexis Inc Azioni (SCYX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.31
price up icon 1.34%
$15.02
price up icon 0.60%
$9.37
price up icon 1.41%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 1.32%
$133.66
price up icon 0.69%
$305.61
price up icon 2.59%
Capitalizzazione:     |  Volume (24 ore):